http://www.futureprescriber.co.uk Future Prescriber news RSS Feed http://www.futureprescriber.co.uk/details/news/1311547/Ezetimibesimvastatin_cuts_cardiovascular_events_in_CKD.html Treatment with ezetimibe plus simvastatin (Inegy) significantly reduced major atherosclerotic events in patients with chronic kidney disease (CKD), whether or not they were on dialysis, the SHARP study has shown (Lancet 2011;377;2181–92). 2011-08-08T11:53:00Z http://www.futureprescriber.co.uk/details/news/1311545/Funding_for_tailored_cancer_treatment.html The Technology Strategy Board has announced Government funding totalling £6 million to support research into tumour profiling and data capture so that cancer treatments can be more accurately targeted to individual patients. 2011-08-08T11:52:00Z http://www.futureprescriber.co.uk/details/news/1311543/Once-weekly_exenatide_approved.html Bydureon, an extended-release formulation of exenatide 2mg, has received marketing approval in the EU, making it the first once-weekly GLP-1 agonist to reach the market. 2011-08-08T11:50:00Z http://www.futureprescriber.co.uk/details/news/1311541/Nalmefene_submission.html Lundbeck says it will apply for EU marketing authorisation for nalmefene, its treatment for alcohol dependence, by the year end. 2011-08-08T11:49:00Z http://www.futureprescriber.co.uk/details/news/1311539/Apixaban_in_AF.html Apixaban (Eliquis), the oral direct Factor Xa inhibitor, is noninferior to warfarin in the prevention of stroke and systemic embolism in patients with atrial fibrillation plus at least one additional risk factor for stroke, say joint developers Bristol-Myers 2011-08-08T11:48:00Z